RCS - Agronomics Limited - Agronomics portfolio company Bond Pet Foods Update

AgronomicsAnnouncement

Thu 18:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260604:nRSD1024Ha&default-theme=true

RNS Number : 1024H  Agronomics Limited  04 June 2026

Agronomics portfolio company Bond Pet Foods receives FDA no-objection letter
for Lamb Protein Yeast

("Agronomics" or the "Company")

 

Agronomics Limited (LSE: ANIC), a leading listed company in the field of clean
food, announces that portfolio company Bond Pet Foods Inc ("Bond") has
received a Letter of No Objection from the US Food and Drug Administration's
Center for Veterinary Medicine ("FDA") in respect of its Lamb Protein Yeast
ingredient for use in pet food.

 

Developed in collaboration with Hill's Pet Nutrition, Inc ("Hill's"), Lamb
Protein Yeast is, to the company's knowledge, the first animal protein
produced via precision fermentation to complete the FDA's Generally Recognised
as Safe review process for use in pet food for healthy adult dogs.

 

The no-objection determination follows a six-month longitudinal feeding study
in dogs and represents an important regulatory step towards commercialisation.
The ingredient has a complete amino acid profile with nutritional
characteristics comparable to conventional lamb protein and has been cleared
for inclusion in adult dog food at levels of up to 15% of the finished
product.

 

Bond and Hill's have also completed feeding studies in cats using Lamb Protein
Yeast and are preparing further submissions to the FDA in support of feline
applications.

 

The Company believes this development represents a further validation of
precision fermentation as a scalable route to producing alternative proteins
for companion animal nutrition.

 

Jim Mellon, Executive Chair of Agronomics, commented: "This is a significant
regulatory milestone for Bond and an important step towards commercialisation.
The outcome supports the potential application of precision fermentation in
pet food and reflects the progress being made by Bond with a major industry
partner."

 

The full announcement is set out below, with no material changes:

 

Hill's Pet Nutrition and Bond Pet Foods Receive FDA No-Objection Letter for
First Animal Protein Produced via Precision Fermentation for Pet Food

 

OVERLAND PARK, Kan. and BOULDER, Colo., May 12, 2026: -- Bond Pet Foods Inc,
an innovative biotechnology company reimagining animal proteins through
precision fermentation, and Hill's Pet Nutrition, Inc, a global leader in
science-led pet nutrition, today announced that Bond has received a US Food
and Drug Administration ("FDA") Center for Veterinary Medicine Letter of No
Objection for its Lamb Protein Yeast ingredient.

 

Developed in collaboration with Hill's after completing a six-month
longitudinal feeding study in dogs, FDA's review and no objection to the
Generally Recognized as Safe (GRAS) Notice marks a major milestone toward
commercialization of a new source of high-quality animal protein for pet food.

 

Lamb Protein Yeast is the first ingredient to emerge from the Hill's-Bond
collaboration to successfully complete FDA's GRAS Notice review process for
healthy adult dogs, supporting use at inclusion levels of up to 15% of the
finished food. This achievement follows several years of joint development
applying precision fermentation-a proven technology long used to produce human
food ingredients for cheesemaking, as well as enzymes and vitamins-to develop
a carefully-selected animal protein ingredient with a complete amino acid
profile that includes nutritional characteristics comparable to a traditional
lamb protein.

 

"We are thrilled to achieve this important regulatory milestone with Hill's,"
said Rich Kelleman, Founder and CEO of Bond Pet Foods. "The results of our
six-month feeding study, together with the FDA's Letter of No Objection,
demonstrate the safety and nutritional performance of our brewed proteins and
bring us a significant step closer to delivering a reliable source of
high-quality protein for pets."

 

Bond and Hill's have also completed the feeding study in cats using Lamb
Protein Yeast and are preparing to submit additional information to FDA's
Center for Veterinary Medicine in support of feline use. This work reflects
the companies' shared commitment to advancing science-based nutrition
solutions for both dogs and cats.

 

"This achievement underscores our long-standing commitment to science-led
innovation in pet nutrition," said Dave Baloga, Executive Vice President,
Science and Technology at Hill's. "Lamb Protein Yeast expands the range of
science-backed nutritional options we can deliver, supporting our
sustainability objectives while maintaining the rigorous nutritional standards
for which Hill's is known."

 

The Hill's-Bond collaboration was first announced in 2021 with the goal of
developing an alternative approach that meets the dietary needs of pets
through established, science-based processes versus utilizing traditional
animal protein ingredients. Key milestones along the way have included the
successful commercial-scale production of Lamb Protein Yeast and the delivery
of more than 25 metric tons to Hill's facilities for formulation, testing and
regulatory evaluation.

 

Bond's precision fermentation platform uses optimized yeast cultures to
produce proteins that are nutritionally comparable to those derived from
conventional animal sources, providing a consistent, scalable and
environmentally responsible protein source for pet food manufacturers.

 

With regulatory status for use in dog food, and work underway to support
feline use, Hill's and Bond are moving into commercialization in the US
market, translating years of joint development into real-world application.

 

About Bond Pet Foods

Bond Pet Foods is a biotechnology company developing animal proteins for pet
nutrition using precision fermentation, enabling the production of
high-quality, sustainable protein ingredients without the use of conventional
animal agriculture.

 

About Agronomics

Agronomics is a leading London-listed company focused on investment
opportunities within the field of clean food. The Company has established a
portfolio of over 20 companies developing technologies that produce food and
materials historically derived from animals, offering solutions for improved
sustainability, human health, and food security.

 

A full list of Agronomics' portfolio companies is available at
www.agronomics.im (http://www.agronomics.im) .

 

For further information, please contact:

 

 Agronomics Limited   Beaumont              Cavendish Capital     Canaccord Genuity     33Seconds

                      Cornish Limited       Markets               Limited               Limited

                                            Limited
 The Company          Nomad                 Joint Broker          Joint Broker          Public Relations
 Jim Mellon           Roland Cornish        Giles Balleny         Andrew Potts          Jack Ferris

 Denham Eke           James Biddle          Michael Johnson       Harry Pardoe          Joel Watson
 +44 (0) 1624 639396  +44 (0) 207 628 3396  +44 (0) 207 397 8900  +44 (0) 207 523 8000  agronomics@33seconds.co

 info@agronomics.im

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an RNS
regulatory announcement and not on Reach.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUPUQAQUPQGQC



            Copyright 2019 Regulatory News Service, all rights reserved